本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

科腾制药

46.49
+0.0000
成交量:- -
成交额:- -
市值:14.98亿
市盈率:8.92
高:46.49
开:46.49
低:46.49
收:46.49
数据加载中...
2022/03/15

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/03/15

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/03/15

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/03/15

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/03/15

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/03/15

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/03/15

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/03/15

重要事件披露

8-K - Current report
2022/03/11

重要事件披露

8-K - Current report
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

重要事件披露

8-K - Current report
2022/01/28

重要事件披露

8-K - Current report
2021/11/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

重要事件披露

8-K - Current report
2021/07/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/29

重要事件披露

8-K - Current report
2021/07/28

重要事件披露

8-K - Current report